Key Takeaways: There is no level of alcohol consumption labeled as “safe” with regard to cancer risk. But the risk is not all-or-nothing. The less alcohol you drink, the more you lower your cancer ...

A structured exercise program after surgery for colon cancer was associated with a reduced risk of disease recurrence and improved survival, according to results from a randomized trial presented at ...

Combining standard adjuvant chemotherapy with the immune checkpoint inhibitor atezolizumab [Tecentriq] leads to a significant improvement in disease-free survival in a subset of patients with Stage ...

T he mortality rate study caught the attention of Scott Atlas, a health policy expert at the Hoover Institution, a conservative public policy think tank. Atlas had opposed lockdowns early in the ...

People who used GLP-1 receptor agonists like Ozempic had a modestly lower risk for obesity-related malignancies, especially colon and rectal cancer.

Jennifer Diamond, MD, medical director of the Cancer Clinical Trials Office, describes how clinical trials lead to new drugs that more effectively treat the disease.

Pregnant women who contract COVID-19 are more likely to become severely ill and to be hospitalized than women who aren’t pregnant.

Adding inavolisib to palbociclib and fulvestrant improved overall survival for people with previously treated PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer.

The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 and projected to exceed 22 million by 2035, according to a new report, ...

An HHS plan implemented under President Joe Biden, including guidance during public health emergencies and disasters, has been archived, meaning it may not reflect current policies. However, HHS’s ...

Maybe it was already there when he was at Disney World. Sitting in his office on a late-winter morning, wearing jeans and a hooded sweatshirt adorned on the front with a teddy bear in a business suit, ...

A top colorectal cancer doc at the University of Colorado shares insights into AI’s many pearls — and potential pitfalls.